Loading…
Baxter International Inc. is projected to rise to $25.99 by 2027, a +15% move from its current price of $22.62. BAX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $22.16 | $22.62 | $23.10 | +0.02% |
| Jul 15 | $21.97 | $22.63 | $23.31 | +0.04% |
| Jul 16 | $21.83 | $22.63 | $23.47 | +0.06% |
| Jul 17 | $21.71 | $22.64 | $23.61 | +0.08% |
| Jul 18 | $21.61 | $22.64 | $23.73 | +0.10% |
| Jul 19 | $21.52 | $22.65 | $23.84 | +0.12% |
| Jul 20 | $21.43 | $22.65 | $23.94 | +0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $21.43 | $22.65 | $23.94 | +0.15% |
| Week 2 | $20.98 | $22.69 | $24.53 | +0.29% |
| Week 3 | $20.64 | $22.72 | $25.00 | +0.44% |
| Week 4 | $20.37 | $22.75 | $25.41 | +0.58% |
| Week 5 | $20.13 | $22.78 | $25.79 | +0.73% |
| Week 6 | $19.93 | $22.82 | $26.13 | +0.87% |
| Week 7 | $19.74 | $22.85 | $26.45 | +1.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Baxter International Inc. is a healthcare company that provides a portfolio of healthcare products in the United States. It operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. The company was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Its products include sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company’s products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. It sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers.
Baxter operates internationally across Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand.
Baxter International Inc. trades under the symbol BAX. The current price is $22.65 and the market capitalization is $11.7B, with a rank of 823.
The price outlook is positive over the longer horizon, with forecast values showing an upward trajectory from 2026 through 2050. The 2026 forecast average is $22.65, rising to $34.52 by 2030, and continuing to higher levels, with a 2040 average of $91.59 and a 2050 average of $153.91. The max forecasts extend to $48.25 in 2030, $145.35 in 2040, and $263.93 in 2050, indicating substantial upside potential over the period.
The corresponding ROI figures show 0% in 2026, then 52.4% in 2030, 304.4% in 2040, and 579.5% in 2050, with a bullish sentiment profile in the later years.
A major floor 30.2% below — a decisive break under it would weaken the trend.
The nearest floor, 18.7% below — buyers have tended to step in here.
Price is pressing into resistance (1.1% away) — a breakout level to watch.
A major ceiling 13.9% above — clearing it would confirm fresh momentum.
Key BAX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BAX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $22.50 | Buy | $22.41 | Buy |
| MA 10 | $22.22 | Buy | $22.09 | Buy |
| MA 20 | $21.32 | Buy | $21.42 | Buy |
| MA 50 | $19.51 | Buy | $20.15 | Buy |
| MA 100 | $18.84 | Buy | $19.66 | Buy |
| MA 200 | $19.54 | Buy | $20.73 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.22 | Neutral |
| Stoch RSI (14) | 64.95 | Neutral |
| CCI (20) | 93.80 | Neutral |
| Williams %R (14) | -7.50 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 12.54 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 92.50 | Sell |
| TRIX (15) | 0.61 | Buy |
| Awesome (5,34) | 2.05 | Buy |
| Ultimate (7,14,28) | 69.88 | Neutral |
| Momentum (10) | 1.07 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 22.55 | Buy |
| ADX (14) | 26.20 | Buy |
| ATR (14) | 0.43 | Info |
The 30-day technical picture is bullish. RSI(14) is 70, signaling near the upper end of the typical bullish range, while the 50-day simple moving average is $19.09 and the 200-day simple moving average is $19.56.
Support stands at $18.40 and resistance at $22.65, with the current 30-day price range spanning from $19.59 to $26.18. The annualized volatility is 40%, indicating elevated near-term risk relative to broad markets.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $15.80 | $22.62 | $28.27 | 0% | Neutral | |
| $21.14 | $25.99 | $33.51 | +15% | Neutral | |
| $22.60 | $28.36 | $37.66 | +25% | Bullish | |
| $24.83 | $31.71 | $43.09 | +40% | Bullish | |
| $27.70 | $35.91 | $49.75 | +59% | Bullish | |
| $32.63 | $42.88 | $60.43 | +90% | Bullish | |
| $37.64 | $50.10 | $71.71 | +122% | Bullish | |
| $39.80 | $53.60 | $77.79 | +137% | Bullish | |
| $41.89 | $57.04 | $83.87 | +152% | Bullish | |
| $43.12 | $59.35 | $88.31 | +162% | Bullish | |
| $70.01 | $101.09 | $158.25 | +347% | Bullish | |
| $110.30 | $172.53 | $291.11 | +663% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $15.80 | $22.62 | $27.22 | +0.00% |
| August 2026 | $19.54 | $22.92 | $27.50 | +1.33% |
| September 2026 | $19.55 | $23.05 | $27.89 | +0.57% |
| October 2026 | $19.91 | $23.58 | $28.74 | +2.29% |
| November 2026 | $19.72 | $23.45 | $28.76 | -0.53% |
| December 2026 | $19.21 | $22.92 | $28.27 | -2.27% |
Click any year to see its month-by-month BAX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect BAX to range from $15.80 to $28.27 through 2026. The $22.62 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The BAX price prediction for 2027 points to an average of $25.99 (low $21.14, high $33.51) — a potential gain of +15% on today's $22.62. A consolidation phase looks the most probable path here.
In 2028, BAX is projected to trade between $22.60 and $37.66, averaging $28.36 — a potential gain of +25% from today's $22.62. That is up +9% on the projected 2027 average. Momentum favours further upside here.
Baxter International Inc.'s 2029 outlook centres on $31.71, within a $24.83 to $43.09 range. That is up +12% on the projected 2028 average. That marks a +40% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, BAX could reach as high as $49.75, with a base case around $35.91 and support toward $27.70 — roughly +59% from $22.62. Momentum favours further upside here.
Expect BAX to range from $32.63 to $60.43 through 2031. The $42.88 average target implies a +90% move from current prices. That is up +19% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The BAX price prediction for 2032 points to an average of $50.10 (low $37.64, high $71.71) — a potential gain of +122% on today's $22.62. Momentum favours further upside here.
In 2033, BAX is projected to trade between $39.80 and $77.79, averaging $53.60 — a potential gain of +137% from today's $22.62. That is up +7% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Baxter International Inc.'s 2034 outlook centres on $57.04, within a $41.89 to $83.87 range. That is up +6% on the projected 2033 average. That marks a +152% change versus current levels. Momentum favours further upside here.
By 2035, BAX could reach as high as $88.31, with a base case around $59.35 and support toward $43.12 — roughly +162% from $22.62. Buyers look set to stay in control over this stretch.
Expect BAX to range from $70.01 to $158.25 through 2040. The $101.09 average target implies a +347% move from current prices. That is up +70% on the projected 2035 average. Momentum favours further upside here.
The BAX price prediction for 2050 points to an average of $172.53 (low $110.30, high $291.11) — a potential gain of +663% on today's $22.62. Buyers look set to stay in control over this stretch.
Investing $1,000 in BAX today (≈ 44.208665 BAX) could be worth
$7,627.4
+$6,627.4 (+663%) by 2050 · US Dollar
Based on the average projected BAX price of $172.53 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BAXwould be worth at today's price.
$1,000 invested in BAX on Jul 10, 2025 (≈ 33.670033 BAX) would be worth
$761.62
-$238.38 (-23.8%) today · 0.76× · US Dollar
Based on a BAX entry price of $29.7 vs. today's $22.62.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $22.65 | $998.68 | -0.1% |
| 1 month ago | $20.31 | $1,113.74 | +11.4% |
| 3 months ago | $17.15 | $1,318.95 | +31.9% |
| 6 months ago | $20.15 | $1,122.58 | +12.3% |
| 1 year ago | $29.7 | $761.62 | -23.8% |
| All time (5.0y) ago | $81 | $279.26 | -72.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BAX forecast.
Our base-case forecast reaches $45.00 around 2032.
Implied market cap at $45.00: $23.24B
The multi-year forecast depicts a continued bullish trajectory with rising average prices and meaningful upside potential. For 2030, the average price is $34.52 with a min of $26.44 and a max of $48.25, and a 52.4% ROI, signaling a solid longer-term gain. The sentiment for 2030 is BULLISH, consistent with a constructive longer-horizon view.
By 2040, the average price is $91.59 and the max reaches $145.35, with a 304.4% ROI and a BULLISH sentiment. The 2050 forecast shows an average of $153.91 and a max of $263.93, supported by a 579.5% ROI and bullish sentiment. These points illustrate a broad-based upward path with substantial potential upside across the decade and beyond, while acknowledging that forecasts are estimates and not guarantees.
Overall, the long-term view points to rising value and strong upside potential anchored by higher forecast averages in later years, tempered by the inherent uncertainty of market moves and the fact that these are projections rather than promises.
Tap a question to reveal the answer.
The 2030 forecast lists an average price of $34.52, with a min of $26.44 and a max of $48.25, and a 52.4% ROI, with a bullish outlook.
The forecast shows rising average prices and positive ROI in later years (e.g., 2030 52.4%, 2040 304.4%, 2050 579.5%) with bullish sentiment; these are estimates and not guarantees.
Yes. The 2040 max price is $145.35, which exceeds $100; earlier years have lower max values (e.g., 2030 max $48.25).
Current price is $22.65 and market cap is $11.7B.
Bullish sentiment with RSI(14) at 70. The 50-day SMA is $19.09, the 200-day SMA is $19.56. Support is $18.40 and resistance is $22.65. The 30-day price range is $19.59 to $26.18.
Baxter International Inc. Community Discussion
0Share your Baxter International Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.